Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

The results of a 10-year phase 1 trial testing an experimental breast cancer vaccine have been published in JAMA Oncology. A larger phase 2 trial testing efficacy is now underway. (New Atlas)

In the United Kingdom, small amounts of lab-manufactured blood are being tested for the first time in a clinical trial. (BBC News)

Mathini Ilancheran, of Beroe Inc., looks at new legislation that may effect India's pharmaceutical and medical device importation, production, and distribution markets. (Clinical Leader)

The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!

‍

‍

‍

Our Culture

“Technology and process improvements will continue to decrease our timelines on creating specifications by 50 percent or more, this year. The more we continue to improve the faster we will be.”

 –Jamie, Trial Delivery‍
‍
‍

‍‍

‍

‍

About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.